Apatinib-based neoadjuvant regimens show promise in resectable gastric cancer meta-analysis
A pooled analysis of 19 studies finds that neoadjuvant apatinib-based regimens achieve a 21 percent pathologic complete response rate in ...
Tag: VEGFR2 inhibitor
POPULAR NEWS
-
Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone
-
Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes
-
Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells
-
New Scale Measures How Ready Nurse Educators Really Are for the AI Era